Ignite Creation Date:
2025-12-24 @ 12:15 PM
Ignite Modification Date:
2025-12-31 @ 3:30 PM
Study NCT ID:
NCT04296461
Status:
UNKNOWN
Last Update Posted:
2021-01-22
First Post:
2020-03-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell Lymphoma
Sponsor:
UWELL Biopharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-27
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-03-02
First Submit QC Date:
None
Study First Post Date:
2020-03-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-16
Last Update Post Date:
2021-01-22
Last Update Post Date Type:
ACTUAL